Condition
Dermatitis, Atopic clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Dermatitis, Atopic clinical trials that are recruiting, at sites in 12 countries (most in United States (3), Spain (2), China (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (3), Phase 3 (2), Phase 1 (1). The most active sponsors are Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (2), Pfizer (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1New in 30 days
- 12Countries
Newest Dermatitis, Atopic clinical trials
All recruiting trials (9)
-
AR100DP1 cream for mild to moderate atopic dermatitis
This study tests whether a 0.5% AR100DP1 topical treatment can help people with mild to moderate atopic dermatitis better than placebo over 14 days.
-
611 in Chinese children with moderate to severe atopic dermatitis
A Phase 3 study tests whether 611 helps kids aged 2 to under 12 with moderate to severe atopic dermatitis compared with a placebo.
-
First-in-human test of DCY636 in healthy adults and in people with moderate to severe atopic dermatitis
This study will test whether DCY636 is safe and tolerated in healthy adults and whether it can be safely given to people with moderate to severe atopic dermatitis.
-
Camoteskimab in adults with moderate-to-severe atopic dermatitis
This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.
-
Testing 611 for moderate to severe atopic dermatitis in Chinese adolescents
This test will see if 611 helps Chinese adolescents (ages 12–17) with moderate to severe atopic dermatitis compared with a matching placebo over about 64 weeks.
-
Abrocitinib for moderate-to-severe atopic dermatitis after inadequate response to biologics
This study will try abrocitinib in adolescents and adults (≥12 years) with moderate-to-severe atopic dermatitis who didn't respond to or couldn't tolerate up to two biologic treatments to see how it works in routine care.
-
Registry assessing therapies for atopic dermatitis in Spain
This study collects information on how well different treatments for atopic dermatitis work and their safety to help improve the quality of life for both kids and adults.
-
Observing the effects of Cibinqo in patients with atopic dermatitis
This study is testing how well Cibinqo works and how safe it is for people aged 12 and older with moderate to severe atopic dermatitis in Korea over about a year.
-
Investigating how eczema treatments affect skin bacteria
This study is testing how different eczema treatments affect the skin bacteria in people with moderate to severe eczema and healthy volunteers.
Related topics
Quick answers
How many Dermatitis, Atopic clinical trials are recruiting right now?
9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (3 trials), Spain (2 trials), China (2 trials), Japan (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.